TaiGen Acquires Global Rights to Warner Chilcott’s Late-Stage Antibiotic – Genetic Engineering News

TaiGen Biotechnology acquired worldwide rights to the non-fluorinated quinolone antibiotic nemonoxacin, from Warner Chilcott. Taiwanese firm TaiGen had previously licensed rights to nemonoxacine in 10 Asian countries, and worldwide development …